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Klippel-Trenaunay syndrome is a rare congenital vascular disorder, and only few cases have been described in pregnancy. We
describe two cases, in one patient without complications, the other patient developed postpartum deep venous thrombosis.
1.Introduction
Klippel-Trenaunay syndrome is a congenital vascular disor-
der characterized by cutaneous hemangiomas, venous vari-
cosities, and limb hypertrophy. Both obstetric and anesthetic
management in these cases can be rather complicated. We
report on two cases.
Case 1. A 33-year Caucasean woman had the diagnosis of
Klippel-Trenaunay syndrome at age 5. As a child, some of
the hemangiomata on the lower limb had been irradiated
with radioactive cobalt. No further details on her childhood
therapy could be found. Her body weight was 63kg. She had
never suﬀered any thrombosis.
During pregnancy, low-molecular-weight heparine nad-
roparin was started from 12 weeks on (nadroparin sin-
gle daily subcutaneous dose 0.3mL) (i.e., 2850 anti Xa,
injection of Fraxiparine, Glaxo Smith Kline, Genval, Bel-
gium),becausethepatientcomplainedofprogressivepainful
swelling and pain in the right leg; Doppler examination
demonstrated no thrombosis.
At 36 weeks of gestational age, magnetic resonance image
(MRI) of the lumbosacral region was performed which
demonstrated some dilation of the anterior epidural venous
plexus at the level lumbal 4-lumbal 5, but no arguments for
anarteriovenousorvenousmalformationinthespinalcanal.
At 39 weeks, she went into spontaneous labour and had
a spontaneous delivery of a baby girl, weighting 2770 gram,
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of oxytocine as prevention for postpartum hemorrhage, this
is a standard procedure for all patients in our center. The
subcutaneouslow-molecular-weightheparinewascontinued
for six weeks after delivery. There were no problems in the
postpartum period.
Case2. A36-year-oldCaucaseanwomanpresentedforaﬁrst
pregnancy. Diagnosis of Klippel-Trenaunay syndrome was
made shortly after birth. She suﬀered from hypertrophy of
the right leg 4cm longer than left leg, atypically localized
varices with an absent deep venous system at the right leg,
and port-wine stains in multiple dermatomes on the right
leg, abdomen, thorax, neck, face, and arms for which she
had received cutaneous lasertherapy. There was no history
of thrombosis. During pregnancy, no low-weight heparine
nor low-dose acetylsalicylic acid was given. The patient did
not demonstrate any change in her lower limbs during
pregnancy. At 36 weeks, MRI of the lumbosacral spine
proved to be impossible because the patient demonstrated
severe claustrophobia.
At 40 weeks, she went in spontaneous labour and a boy,
weighing 3690 gram, Apgar 8 and 9 after 1 and 5 minutes
was spontaneously born. Immediately after delivery, low-
molecular-weight heparine was started (Fraxiparine 0.3mL,
Glaxo Smith Kline, Genval, Belgium). She left the hospital
on the fourth postpartum day and continued the use of
nadroparin.Onthe13thday,shedevelopedacutephlegmasia
alba dolens with complete thrombosis of the superﬁcial
veins of the right leg. Treatment consisted of compressive2 Obstetrics and Gynecology International
stockings and intermittent pneumatic compression together
with a therapeutic dose of low-molecular-weigh heparine
(Fraxodine 0.8mL, Glaxo Smith Kline, Genval, Belgium,
nadroparine 15200IE anti Xa once daily subcutaneously).
On the same day under local anesthesia, a trombectomy was
performedthroughaninguinalincisiontoremovethelargest
trombi on the level of the lateral and anterior side of the
right upper leg. In one week time, there was spectacular
diminishment of the swelling of the right upper leg which
went from 10cm diﬀerence with the left upper leg to 2cm
in circumference. The low-molecular-weight heparin and
elastic compressive stockings were continued for six weeks
after the event.
2. Discussion
Klippel-Trenaunay syndrome was ﬁrst described in 1900 by
two French physicians, Maurice Klippel and Paul Trenau-
nay. They called the disease naevus vasculosus osteohyper-
trophicus. The diagnostic criteria are capillary malforma-
tions, venous malformations and/or varicosities, and hyper-
trophy of the bone or soft tissues in one or more extremity
[1].
Vasculardiseasecanalsobepresentintheinternalorgans
such as the intestines or the uterus.
In 1907, Frederick Parkes Weber demonstrated that in
this disease there was presence of arteriovenous ﬁstula,
since the syndrome has also been described as a Klippel-
Trenaunay-Weber syndrome or angioosteohypertrophy syn-
drome [2]. Today, Klippel-Trenaynay syndrome is deﬁned
by the presence of a combined vascular malformation of
the capillaries, veins, and lymphatics with congenital venous
abnormalities and limb hypertrophy and is distinguished
from Parkes-Weber syndrome in which an arteriovenous
malformation with a cutaneous capillary malformation and
skeletal or soft tissue hypertrophy occurs [3]. Both our
patients demonstrated Klippel-Trenaunay syndrome.
The etiology of the syndrome is unknown. Several
theories have been proposed including abnormalities of
the sympathic nerve system resulting in dilatation of the
arteriovenous anastomosis or obstruction of the deep veins
and persistence of fetal microscopic small arterioveneous
anastomosis [2].
Klippel-Trenaunay syndrome has a sporadic occurrence
worldwide, we were unable to ﬁnd any data linking the
syndrome to speciﬁc ethnic groups. In about 1% of cases
of Klippel-Trenaunay syndrome, a genetic pattern has been
described, but the gene has not yet been identiﬁed [4–
6]. It has been associated with an increased parental age
and number of previous pregnancies [7]. The port-wine
stains in Klippel-Trenaunay syndrome are mainly on the
legs, less frequently on the arms of the trunk, and extremely
rarely on the head or neck. They never exceed the midline.
The varicosities on the legs result in a “Klippel-Trenaunay”
vein. These varicosities increase in size during pregnancy.
Hypertrophy of the soft tissues and bones leads to diﬀer-
ences in leg length. Other described abnormalities include
deep vein thrombosis, hypospadias, and lymph obstruction.
At least two of three main symptoms (port-wine stains,
varicosity, and hypertrophy of soft tissues and bones) must
be present for the diagnosis Klippel-Trenaunay syndrome to
be accepted.
Klippel-Trenaunay syndrome in a pregnant women is
extremely rare, and only 19–20 cases have been published
in the English language literature (summarized by Rebarber
et al. [8] and 4 cases published later [9–12]). The normal
physiologic changes of pregnancy, such as increased venous
pressure, leg edema, venous stasis, and cardiac output,
exacerbate the problems of this syndrome, resulting in
an increased risk of thromboembolism and haemorrhage.
Massive bleeding into the rectum, vagina, or vulva and
vulvovaginal varicosities obstruction in the vaginal introitus
have been described. An increased risk for intrauterine
growth restriction has also been reported. As the disease can
be hereditary in rare cases, the fetus should be checked for or
the prenatal diagnosis of limb hypertrophy or multiloculated
cystic lesions at the level of the thorax abdominal wall or
limbs, what can be easily performed by fetal colour Doppler
ﬂow, which at the same moment can display eventual
oaternal uterine angiomata, possibly complicating caesarean
section. Diﬀerent reports on prenatal diagnosis of Klippel-
Trenaunay syndrome in fetuses have been published [13].
It has been suggested that these patients should be
monitored for coagulopathies and screened for hereditary
and acquired thrombophilic disorders. There is an ungoing
discussion on the use of anticoagulant therapy including
low-dose aspirine or low-molecular-weigh heparine during
pregnancy. Due to increased swelling of the lower limbs,
anticoagulant therapy was started in the ﬁrst patient, in the
second case, the anticoagulation was started only after deliv-
ery as the patient was considered high risk for postpartum
thrombosis due to the varicosities. Despite the prophylactic
low-molecular-weight heparin, she developed thrombosis;
we do not know whether antepartum anticoagulant therapy
could have prevented this complication. Coagulopathy is the
most reported complication during pregnancy in women
with Klippel-Trenaunay syndrome, including deep venous
thrombosis and other tromboembolic problems both during
and after delivery. Probably the risk is 10 times higher than
in the normal population. There are no prospective trials on
the use of anticoagulants and during pregnancy in Klippel-
Trenaunay syndrome, so this should be discussed on an
individual basis. If the patient had a tromboembolic acci-
dent in the past, therapeutic coagulation is indicated [14].
Antithrombotic stockings are generally advised. Kasabach-
Merritsyndrome,whichisadiﬀuseintravascularcoagulation
associated with major vascular malformations, has been
reported [15].
The presence of neuraxial vascular anomalies can com-
plicate locoregional anaesthesia. It is advised to perform
magnetic resonance imagining to detect angiodysplastic vas-
cular structures next to the spinal cord (posterior cutaneous
hemangioma, epidural andsubdural vascularmalformation)
to avoid in these cases a traumatic puncture of these vessels.
A multidisciplinary approach with the gynecologist,
anesthesiologist, and vascular surgeon or haematologist
forms the mainstay of the management of these patients.Obstetrics and Gynecology International 3
There is no indication for cesarean section, except for
the usual obstetric indication, cesarean section can be com-
plicated by abdominal wall or uterine varices and heman-
giomata. In the postpartum period, prophylactic anticoag-
ulation is generally advised.
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